AMPH · All filings · Read this filing
What changed 10-K
Item 2. Properties
2022-03-11 compared with 2021-03-15 · 0 added, 4 removed, 42 unchanged (9% of the section changed)
6 unchanged sentences
We continue to expand our facility in Nanjing, China and expect further significant investment.
−Removed: In April 2014, we acquired Merck’s API manufacturing business in Éragny-sur-Epte, France, which manufactures porcine insulin API and recombinant human insulin API, and expect to continue the current site activities.
The following table provides a summary of our owned properties as of December 31, 2021:
20 unchanged sentences
(in square feet)
−Removed: Nanjing, China
−Removed: Manufacturing, laboratories and administrative offices
−Removed: Finished pharmaceutical products
Rancho Cucamonga, CA
12 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.